Event Brief
Apr 23, 2026 at 6:00 PM ET
FDA approves first gene therapy for hearing loss
By The BriefBrief
The FDA approved Regeneron’s Otarmeni, the first gene therapy for genetic hearing loss.
WHO: Food and Drug Administration
WHAT: approved Regeneron’s Otarmeni
WHEN: Apr 23, 2026 at 4:47 PM ET
WHERE: USA
WHY: Part of a scheduled process.
Reporting from 2 identified publishers across this event arc.
View all 2 publishers
Publishers represented across this event arc
These publishers contributed reporting to the broader event history. Not every source addresses the specific development described above.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
US reclassifies medical marijuana as less dangerous
Trump Administration
Apr 23, 2026 at 6:00 PM ET
Air Force extends A-10 service through 2030
Air Force
Apr 23, 2026 at 6:00 PM ET
Ford class review questions Navy carrier plans
The War Zone
Apr 23, 2026 at 6:00 PM ET
US officials voice concerns over China, Pacific defense
China
Apr 23, 2026 at 6:00 PM ET
Page 22954 of 25521
Same format. Every time.
Continue reading — sign in or create a free account with
